Neuropeptide Y in brains of the Flinders Sensitive Line rat, a model of depression. Effects of electroconvulsive stimuli and d-amphetamine on peptide concentrations and locomotion

Behavioural Brain Research

Volumn 111, Issue 1-2, 2000, Pages 115-123

  Jiménez Vasquez, Patricia A ^a   Salmi, Peter ^b   Ahlenius, Sven ^b   Mathé, Aleksander A ^a  

^a Psychiatry Section   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Amphetamine; Animal model of depression; Dopamine; Electroconvulsive stimuli; Locomotor activity; Neuropeptide Y

Indexed keywords

DEXAMPHETAMINE; NEUROPEPTIDE Y;

ANIMAL MODEL; ARTICLE; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; DEPRESSION; ELECTROCONVULSIVE THERAPY; FRONTAL CORTEX; HABITUATION; HIPPOCAMPUS; HYPOTHALAMUS; LOCOMOTION; MALE; NONHUMAN; OCCIPITAL CORTEX; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT;

ANIMALS; DEPRESSION; DEXTROAMPHETAMINE; DISEASE MODELS, ANIMAL; DOPAMINE; ELECTROCONVULSIVE THERAPY; HIPPOCAMPUS; LOCOMOTION; MALE; NEUROPEPTIDE Y; RATS; RATS, INBRED STRAINS;

EID: 0342657119     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(00)00142-X     Document Type: Article

References (68)

1. 3H]dopamine release from rat prefrontal cortex is reversed by sigma1 receptor antagonists. Schizophr. Res. 31:1998;27-36.
2. Beal M.F., Frank R.C., Ellison D.W., Martin J.B. The effect of neuropeptide Y on striatal catecholamines. Neurosci. Lett. 71:1986;118-123.
3. Bellmann R., Sperk G. Effects of antidepressant drug treatment on levels of NPY or prepro-NPY-mRNA in the rat brain. Neurochem. Int. 22:1993;183-187.
4. Berrettini W.H., Doran A.R., Kelsoe J., Roy A., Pickar D. Cerebrospinal fluid neuropeptide Y in depression and schizophrenia. Neuropsychopharmacology. 1:1987;81-83.
5. Caberlotto L., Fuxe K., Overstreet D.H., Gerrard P., Hurd Y.L. Alterations in neuropeptide Y and Y1 receptor mRNA expression in brains from an animal model of depression: region specific adaptation after fluoxetine treatment. Brain Res. Mol. Brain Res. 59:1998;58-65.
6. Caberlotto L., Jiménez P., Overstreet D.H., Hurd Y.L., Mathé A.A., Fuxe K. Alterations in Neuropeptide Y levels and Y1 bindings sites in the Flinders Sensitive rats, a genetic animal model of depression. Neurosci. Lett. 263:1999;191-194.
7. De Sauza E.B., Grigoriadis D.E. Corticotropin-releasing factor. Physiology, pharmacology, and role in central nervous system and disorders. Bloom F.E., Kupfer D.J. Psychopharmacology: The Fourth Generation of Progress. 1995;505-517 Raven Press, New York.
8. Deakin J.F., Owen F., Cross A.J., Dashwood M.J. Studies on possible mechanisms of action of electroconvulsive therapy; effects of repeated electrically induced seizures on rat brain receptors for monoamines and other neurotransmitters. Psychopharmacology (Berl.). 73:1981;345-349.
9. Drumheller A., Bouali S.M., Fournier A., St-Pierre S., Jolicoeur F.B. Neurochemical effects of neuropeptide Y (NPY) and NPY2-36. Neuropeptides. 27:1994;291-296.
10. Ericson E., Samuelsson J., Ahlenius S. Photocell measurements of rat motor activity. A contribution to sensitivity and variation in behavioral observations. J. Pharmacol. Methods. 25:1991;111-122.
11. Finta E.P., Regenold J.T., Illes P. Depression by neuropeptide Y of noradrenergic inhibitory postsynaptic potentials of locus coeruleus neurones. Naunyn Schmiedebergs Arch. Pharmacol. 346:1992;472-474.
12. Gjerris A., Widerlöv E., Werdelin L., Ekman R. Cerebrospinal fluid concentrations of neuropeptide Y in depressed patients and in controls. J. Psychiatry Neurosci. 17:1992;23-27.
13. Glowinski J., Iversen L.L. Regional studies of catecholamines in the rat brain: The disposition of (3H) norepinephrine, (3H) dopamine and (3H) dopa in various regions of the brain. J. Neurochem. 13:1965;655-669.
14. Green A.R., Heal D.J., Grahame-Smith D.G. Further observations on the effect of repeated electroconvulsive shock on the behavioural responses of rats produced by increases in the functional activity of brain 5-hydroxytryptamine and dopamine. Psychopharmacology (Berl.). 52:1977;195-200.
15. Gruber S., Haij K., Mathé A.A. Novel action of psychotomimetic drugs: amphetamine, phencyclidine and MK-801 affect neuropeptides in brain. Psychopharmacology. 118:1995;B9.
16. Gruber S., Mathé A.A. Both antipsychotic drugs and psychotomimetic compounds affect peptides in brain. Nordic J. Psychiatry. 50:1996;106.
17. Gulati A., Srimal R.C., Dhawan K.N., Dhawan B.N. On the mechanism of potentiation of apomorphine-induced stereotypy due to electroconvulsive shock. Neuropharmacology. 26:1987;1733-1737.
18. Heilig M., Ekman R. Chronic parenteral antidepressant treatment in rats: unaltered levels and processing of neuropeptide Y (NPY) and corticotropin-releasing hormone (CRH). Neurochem. Int. 26:1995;351-355.
19. Heilig M., Vecsei L., Wahlestedt C., Alling C., Widerlöv E. Effects of centrally administered neuropeptide Y (NPY) and NPY13-36 on the brain monoaminergic systems of the rat. J. Neural Transm. Gen. Sect. 79:1990;193-208.
20. Hertel P., Mathé J.M., Nomikos G.G., Iurlo M., Mathé A.A., Svensson T.H. Effects of D-amphetamine and phencyclidine on behavior and extracellular concentrations of neurotensin and dopamine in the ventral striatum and the medial prefrontal cortex of the rat. Behav. Brain Res. 72:1995;103-114.
21. Jiménez P., Mathé A.A. Brain neuropeptides in animals model of depression. Effects of electroconvulsive treatments. Nordic J. Psychiatry. 50:1996;92.
22. Jiménez P., Darenberg J., Overstreet D.H., Mathé A.A. Are male and female brain different? Analysis of neuropeptides and monoamines in rat brain regions. Biol. Psychiatry. 42:1997;235.
23. Josselyn S.A., Beninger R.J. Neuropeptide Y: intraaccumbens injections produce a place preference that is blocked by cis-flupenthixol. Pharmacol. Biochem. Behav. 46:1993;543-552.
24. Lachman H.M., Papolos D.F., Weiner E.D., Ramazankhana R., Hartnick C., Edwards E., Henn F.A. Hippocampal neuropeptide Y mRNA is reduced in a strain of learned helpless resistant rats. Mol. Brain Res. 14:1992;94-100.
25. Lerer B., Sitaram N. Clinical strategies for evaluating ECT mechanisms - pharmacological, biochemical and psychophysiological approaches. Prog. Neuropsychopharmacol. Biol. Psychiatry. 7:1983;309-333.
26. Lerer B. Neurochemical and other neurobiological consequences of ECT: Implications for the pathogenesis and treatment of affective disorders. Meltzer H.Y. Psychopharmacology: The Third Generation of Progress. 1987;557-587 Raven Press, New York.
27. Maj J., Wedzony K., Klimek V. Desipramine given repeatedly enhances behavioural effects of dopamine and d-amphetamine injected into the nucleus accumbens. Eur. J. Pharmacol. 140:1987;179-185.
28. Maj J., Rogoz Z., Skuza G., Sowinska H. Antidepressants given repeatedly increase the behavioural effect of dopamine D-2 agonist. J. Neural Transm. Gen. Sect. 78:1989;1-8.
29. 3H]noradrenaline release from rat brain synaptosomes by neuropeptide Y-(13-36). Involvement of NPY receptors of the Y2 type. Eur. J. Pharmacol. 230:1993;231-234.
30. Mathé A.A., Stenfors C., Brodin E., Theodorsson E. Neuropeptides in brain: effects of microwave irradiation and decapitation. Life Sci. 46:1990;287-293.
31. Mathé A.A., Jousisto-Hanson J., Stenfors C., Theodorsson E. Effect of lithium on tachykinins, calcitonin gene-related peptide, and neuropeptide Y in rat brain. J. Neurosci. Res. 26:1990;233-237.
32. Mathé A.A., Norstedt-Wikner B., Stenfors C., Theodorsson E. Effects of lithium on neuropeptide Y, neurokin A, and substance P in brain and peripheral tissues of rat. Lithium. 5:1994;241-247.
33. Mathé A.A., Hertel P., Nomikos G.G., Gruber S., Mathé J.M., Svensson T.H. The psychotomimetic drugs D-amphetamine and phencyclidine release calcitonin gene-related peptide in the limbic forebrain of the rat. J. Neurosci. Res. 46:1996;316-323.
34. Mathé A.A., Rudorfer W.V., Stenfors C., Manji H.K., Potter W.Z., Theodorsson E. Effects of electroconvulsive treatment on somatostatin, neuropeptide Y, endothelin, and neurokinin A concentrations in cerebrospinal fluid of depressed patients. Depression. 3:1996;250-256.
35. Mathé A.A., Gruber S., Jiménez P.A., Theodorsson E., Stenfors C. Effects of electroconvulsive stimuli and MK-801 on neuropeptide Y, neurokinin A, and calcitonin gene-related peptide in rat brain. Neurochem. Res. 22:1997;629-636.
36. Mathé A.A., Jiménez P.A., Theodorsson E., Stenfors C. Neuropeptide Y, neurokinin A and neurotensin in brain regions of Fawn Hooded 'depressed', Wistar, and Sprague-Dawley rats. Effects of electroconvulsive stimuli. Prog. Neuropsychopharmacol. Biol. Psychiatry. 22:1998;529-546.
37. Mathé A.A. Neuropeptides and electroconvulsive treatment. J. ECT. 15:1999;60-75.
38. Mikkelsen J.D., Woldbye D., Kragh J., Larsen P.J., Bolwig T.G. Electroconvulsive shocks increase the expression of neuropeptide Y (NPY) mRNA in the piriform cortex and the dentate gyrus. Brain Res. Mol. Brain Res. 23:1994;317-322.
39. Modigh K. Electroconvulsive shock and postsynaptic catecholamine effects: increased psychomotor stimulant action of apomorphine and clonidine in reserpine pretreated mice by repeated ECS. J. Neural Transm. 36:1975;19-32.
40. Modigh K., Balldin J., Eden S., Granerus A.K., Walinder J. Electroconvulsive therapy and receptor sensitivity. Acta Psychiatr. Scand. Suppl. 290:1981;91-99.
41. Moore E., Merali Z., Beninger R.J. Neuropeptide Y: intrastriatal injections produce contralateral circling that is blocked by a dopamine antagonist in rats. Pharmacol. Biochem. Behav. 48:1994;681-688.
42. Nomikos G.G., Zis A.P., Damsma G., Fibiger H.C. Effects of chronic electroconvulsive shock on interstitial concentrations of dopamine in the nucleus accumbens. Psychopharmacology (Berl.). 105:1991;230-238.
43. Nomikos G.G., Zis A.P., Damsma G., Fibiger H.C. Electroconvulsive shock produces large increases in interstitial concentrations of dopamine in the rat striatum: an in vivo microdialysis study. Neuropsychopharmacology. 4:1991;65-69.
44. Ordway G.A., Stockmeier C.A., Meltzer H.Y., Overholser J.C., Jaconetta S., Widdowson P.S. Neuropeptide Y in frontal cortex is not altered in major depression. J. Neurochem. 65:1995;1646-1650.
45. Overstreet D.H. The Flinders sensitive line rats: a genetic animal model of depression. Neurosci. Biobehav. Rev. 17:1993;51-68.
46. Overstreet D.H., Pucilowski O., Rezvani A.H., Janowsky D.S. Administration of antidepressants, diazepam and psychomotor stimulants further confirms the utility of Flinders Sensitive Line rats as an animal model of depression. Psychopharmacology (Berl.). 121:1995;27-37.
47. Reches A., Wagner H.R., Barkai A.I., Jackson V., Yablonskaya-Alter E., Fahn S. Electroconvulsive treatment and haloperidol: effects on pre- and postsynaptic dopamine receptors in rat brain. Psychopharmacology (Berl.). 83:1984;155-158.
48. Rubinow D.R., Davis C.L., Post R.M. Somatostatin in the Central Nervous System. Bloom F.E., Kupfer D.J. Psychopharmacology: The Fourth Generation of Progress. 1995;553-562 Raven Press, New York.
49. Sakai K., Maeda K., Chihara K., Kaneda H. Increases in cortical neuropeptide Y and somatostatin concentrations following haloperidol-depot treatment in rats. Neuropeptides. 29:1995;157-161.
50. Smialowska M. An inhibitory dopaminergic regulation of the neuropeptide Y immunoreactivity expression in the rat cerebral cortex neurons. Neuroscience. 66:1995;589-595.
51. Stenfors C., Theodorsson E., Mathé A.A. Effect of repeated electroconvulsive treatment on regional concentrations of tachykinins, neurotensin, vasoactive intestinal polypeptide, neuropeptide Y, and galanin in rat brain. J. Neurosci. Res. 24:1989;445-450.
52. Stenfors C., Srinivasan G.R., Theodorsson E., Mathé A.A. Electroconvulsive stimuli and brain peptides: effect of modification of seizure duration on neuropeptide Y, neurokinin A, substance P and neurotensin. Brain Res. 596:1992;251-258.
53. Stenfors C., Mathé A.A., Theodorsson E. Repeated electroconvulsive stimuli: changes in neuropeptide Y, neurotensin and tachykinin concentrations in time. Prog. Neuropsychopharmacol. Biol. Psychiatry. 18:1994;201-209.
54. Stenfors C., Bjellerup P., Mathé A.A., Theodorsson E. Concurrent analysis of neuropeptides and biogenic amines in brain tissue of rats treated with electroconvulsive stimuli. Brain Res. 698:1995;39-45.
55. Stenfors C., Mathé A.A., Theodorsson E. Chromatographic and immunochemical characterization of rat brain neuropeptide Y-like immunoreactivity (NPY-LI) following repeated electroconvulsive stimuli. J. Neurosci. Res. 41:1995;206-212.
56. Theodorsson E., Stenfors C., Mathé A.A. Microwave irradiation increases recovery of neuropeptides from brain tissues. Peptides. 11:1990;1191-1197.
57. Vallejo M., Carter D.A., Biswas S., Lightman S.L. Neuropeptide Y alters monoamine turnover in the rat brain. Neurosci. Lett. 73:1987;155-160.
58. Wahlestedt C., Blendy J.A., Kellar K.J., Heilig M., Widerlöv E., Ekman R. Electroconvulsive shocks increase the concentration of neocortical and hippocampal neuropeptide Y (NPY)-like immunoreactivity in the rat. Brain Res. 507:1990;65-68.
59. Wahlestedt C., Karoum F., Jaskiw G., Wyatt R.J., Larhammar D., Ekman R., Reis D.J. Cocaine-induced reduction of brain neuropeptide Y synthesis dependent on medial prefrontal cortex. Proc. Natl. Acad. Sci. USA. 88:1991;2078-2082.
60. Wahlestedt C., Pich E.M., Koob G.F., Yee F., Heilig M. Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides. Science. 259:1993;528-531.
61. Weiner E.D., Mallat A.M., Papolos D.F., Lachman H.M. Acute lithium treatment enhances neuropeptide Y gene expression in rat hippocampus. Mol. Brain Res. 12:1992;209-214.
62. Widdowson P.S., Halaris A.E. Increased levels of neuropeptide y-immunoreactivity in rat brain limbic structures following antidepressant treatment. J. Neurochem. 52:1989;77-86.
63. Widdowson P.S., Ordway G.A., Halaris A.E. Reduced neuropeptide Y concentrations in suicide brain. J. Neurochem. 59:1992;73-80.
64. Widerlöv E., Lindström L.H., Wahlestedt C., Ekman R. Neuropeptide Y and peptide YY as possible cerebrospinal fluid markers for major depression and schizophrenia, respectively. J. Psychiatr. Res. 22:1988;69-79.
65. Wielosz M. Increased sensitivity to dopaminergic agonists after repeated electroconvulsive shock (ECS) in rats. Neuropharmacology. 20:1981;941-945.
66. Winer BJ. Statistical Principles in Experimental Design. New York: McGraw Hill, 1971.
67. Zachrisson O., Mathé A.A., Stenfors C., Lindefors N. Limbic effects of repeated electroconvulsive stimulation on neuropeptide Y and somatostatin mRNA expression in the rat brain. Mol. Brain Res. 31:1995;71-85.
68. Zachrisson O., Mathé A.A., Stenfors C., Lindefors N. Region-specific effects of chronic lithium administration on neuropeptide Y and somatostatin mRNA expression in the rat brain. Neurosci. Lett. 194:1995;89-92.